SC07-0685 Screening compound: N-{1-[(5-fluoro-2-methylphenyl)sulfonyl]tetrahydro-1H-pyrrol-3-yl}-N-[2-(5-isopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide

SC07-0685 Screening compound: N-{1-[(5-fluoro-2-methylphenyl)sulfonyl]tetrahydro-1H-pyrrol-3-yl}-N-[2-(5-isopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide
SC07-0685 Screening compound: N-{1-[(5-fluoro-2-methylphenyl)sulfonyl]tetrahydro-1H-pyrrol-3-yl}-N-[2-(5-isopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound SC07-0685
N-{1-[(5-fluoro-2-methylphenyl)sulfonyl]tetrahydro-1H-pyrrol-3-yl}-N-[2-(5-isopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

SC07-0685

Molecular Formula

C20H27FN4O4S (C20 H27 FN4 O4 S)

Compound Name

N-{1-[(5-fluoro-2-methylphenyl)sulfonyl]tetrahydro-1H-pyrrol-3-yl}-N-[2-(5-isopropyl-1,2,4-oxadiazol-3-yl)ethyl]acetamide

IUPAC name

N-[1-(5-fluoro-2-methylbenzenesulfonyl)pyrrolidin-3-yl]-N-{2-[5-(propan-2-yl)-124-oxadiazol-3-yl]ethyl}acetamide

SMILES

CC(C)c1nc(CCN(C(CC2)CN2S(c2c(C)ccc(F)c2)(=O)=O)C(C)=O)no1

InChI

InChI=1S/C20H27FN4O4S/c1-13(2)20-22-19(23-29-20)8-10-25(15(4)26)17-7-9-24(12-17)30(27,28)18-11-16(21)6-5-14(18)3/h5-6,11,13,17H,7-10,12H2,1-4H3/t17-/m1/s1

InChI Key

ZMPYNOMDXWSTPX-QGZVFWFLSA-N

MDL Number (MFCD)

MFCD32254095

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

438.52

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.908

Distribution Coefficient, logD

2.908

Water Solubility, LogSw

-3.19

Polar Surface Area

80.898

Acid Dissociation Constant (pKa)

24.94

Base Dissociation Constant (pKb)

-1.13

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

55.00

SC07-0685 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with SC07-0685 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SC07-0685?
Check Price and Availability of SC07-0685, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SC07-0685 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SC07-0685
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SC07-0685
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SC07-0685 available by request